Sernova (TSX:SVA) Repurchase of Stock : C$0.00 Mil (TTM As of Jul. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Repurchase of Stock?

Sernova's Repurchase of Stock for the three months ended in Jul. 2024 was C$0.00 Mil.

Sernova's Repurchase of Stock for the trailing twelve months (TTM) ended in Jul. 2024 was C$0.00 Mil.

Sernova Repurchase of Stock Historical Data

The historical data trend for Sernova's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Repurchase of Stock Chart

Sernova Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Repurchase of Stock

Get a 7-Day Free Trial

Sernova Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Repurchase of Stock	Get a 7-Day Free Trial															-	-	-	-	-

Sernova Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Sernova Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of Sernova's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (TSX:SVA) » Definitions » Repurchase of Stock

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH:Germany PSH:Germany PSH:Germany

Address

700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Executives